Fig. 3From: Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillationForest plot demonstrating the risk of net clinical adverse events (stroke or systemic embolism, bleeding, and death), by anticoagulation therapy according to the stage of chronic kidney diseaseBack to article page